2023 Patents
QPI is pleased to report the issuance of U.S. Patent No., 11,760,639 entitled, "Graphene Nanoplatelets Derived from Thermomechanical Exfoliation of Graphite," on September 19, 2023 to Marianna Kontopoulou and Osayuki Osazuwa. The patent relates to a method of exfoliating layered, shearable material and a machine for preparing nanoplatelets.
QPI is pleased to report the issuance of Canada Patent No. 2,918,136 entitled, "High Sum-Rate Write-Once Memory," on August 15, 2023 to Jay Hua and Shahram Yousefi. The patent relates to methods and constructions for operating a digital memory.
QPI is pleased to report the issuance of Canada Patent No. 2,921,610 entitled, "Carbene Functionalized Composite Materials," on August 1, 2023 to Cathy Crudden, Iraklii Ebralidze, J. Hugh Horton, Christene Smith, and Olena Zenkina. The patent relates to carbene functionalized composite materials and methods of manufacture thereof.
Queen’s Partnerships and Innovation is pleased to report the issuance of U.S. Patent No. 11,711,023 entitled, "Methods and Circuits for Sensing Isolated Power Converter Output Voltage Across the Isolation Barrier," on July 25, 2023 to Yang Chen, Binghui He, Wenbo Liu, Yan-Fei Liu, and Bo Sheng. The patent relates to a control circuit for an isolated power converter.
Queen’s Partnerships and Innovation is pleased to report the issuance of U.S. Patent No. 11,684,258 entitled, "Non-Invasive Intraocular Pressure Monitor," on June 27, 2023 to Robert Campbell, Yong Jun Lai, and Kong Ying Xie. The patent relates to non-invasive devices to monitor and measure intraocular pressure.
Queen’s Partnerships and Innovation is pleased to report the issuance of U.S. Patent No. 11,679,123 entitled, "N-Acylated Hyaluronic Acid for Hyperuricemia and Gouty Arthritis," on June 20, 2023 to Yin Gao and Tassos Anastassiades. The patent relates to a pharmaceutical composition of hyaluronic acid for the treatment of hyperuicemia and gouty arthritis.
Queen’s Partnerships and Innovation is pleased to report the issuance of Canadian Patent No. 3,089,660 entitled, "Resonant Power Converters and Control Methods for Wide Input and Output Voltage Ranges," on May 16, 2023 to Yan-Fei Liu and Yang Chen. The patent relates to resonant converters with wide input and output voltage ranges for suitable use in AC-DC power adapters for portable devices with different voltage requirements.
Queen’s Partnerships and Innovation is pleased to report the issuance of U.S. Patent No. 11,628,226 entitled, "Methods and Gene Therapy Constructs for Treating GM2 Gangliosidoses," on April 18, 2023 to Jagdeep Singh Walia. The patent relates to novel gene therapy constructs containing both HEXA and HEXB genes to treat GM2 gangliosidoses, including Sandhoff disease and Tay-Sach's disease.
Queen’s Partnerships and Innovation is pleased to report the issuance of U.S. Patent No. 11,611,228 entitled, "Power Cycle Modulation Control for Power Converters," on March 21, 2023 to Yan-Fei Liu, Yang Chen and Wenbo Liu. The patent relates to controllers and methods for controlling a resonant power converter output voltage.
Queen’s Partnerships and Innovation is pleased to report the issuance of U.S. Patent No. 11,579,149 entitled, "Hippo Pathway Bioluminescent Biosensor," on February 14, 2023 to Taha Azad, Kazem Nouri, and Xiaolong Yang. The patent relates to bioluminescent sensors useful for monitoring and/or quantifying, in vitro or in vivo, activity of the Hippo signaling pathway.
Queen’s Partnerships and Innovation is pleased to report the issuance of U.S. Patent No. 11,547,325 entitled, "Method and Apparatus for Assessing Sensorimotor Performance," on January 10, 2023 to Kayne Park and Stephen Scott. The patent relates to a method and apparatus for quantifying differences in human sensorimotor performance useful for diagnosing, assessing, and/or detecting brain injury and/or a neurological disorder, or identifying exceptional performance in a subject.